MuSK-antibodies are associated with worse outcome in myasthenic crisis requiring mechanical ventilation

URN to cite this document:: urn:nbn:de:bvb:355-epub-456817
DOI to cite this document:: 10.5283/epub.45681

König, Nicole ; Stetefeld, Henning R. ; Dohmen, Christian ; Mergenthaler, Philipp ; Kohler, Siegfried ; Schönenberger, Silvia ; Bösel, Julian ; Lee, De-Hyung ; Gerner, Stefan T. ; Huttner, Hagen B. ; Schneider, Hauke ; Reichmann, Heinz ; Fuhrer, Hannah ; Berger, Benjamin ; Zinke, Jan ; Alberty, Anke ; Kleiter, Ingo ; Schneider-Gold, Christiane ; Roth, Christian ; Dunkel, Juliane ; Steinbrecher, Andreas ; Thieme, Andrea ; Schlachetzki, Felix

; Linker, Ralf A.

; Angstwurm, Klemens

; Meisel, Andreas ; Neumann, Bernhard

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(868kB)

Date of publication of this fulltext: 14 May 2021 05:47

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Myasthenic crisis (MC) is a life-threatening condition for patients with myasthenia gravis (MG). Muscle-specific kinase-antibodies (MuSK-ABs) are detected in ~ 6% of MG, but data on outcome of MuSK-MCs are still lacking. We made a subgroup analysis of patients who presented with MC with either acetylcholine-receptor-antibody positive MG (AchR-MG) or MuSK-MG between 2006 and 2015 in a ...